Trial
NCT01060254
A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators
—
Condition
Cystitis, Interstitial
Intervention
Placebo
Why stopped
Logistic reasons associated with the FDA-imposed clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-18